Stability of Protein Pharmaceuticals
Part B: In Vivo Pathways of Degradation and Strategies for Protein Stabilization
Seiten
1992
Kluwer Academic/Plenum Publishers (Verlag)
978-0-306-44153-0 (ISBN)
Kluwer Academic/Plenum Publishers (Verlag)
978-0-306-44153-0 (ISBN)
Part B explores protein degradation occuring in vivo during protein synthesis in cells, examines the isolation and purification of proteins, details protein use in organisms, and reviews techniques to enhance protein stability.
Improper Glycosylation and the Cellular Editing of Nascent Proteins; D.A. Cumming. Protein Aggregation In Vivo; R. Wetzel. Pathways of Intracellular Protein Degradation in Eukaryotic Cells; T.S. Olson, et al. Effects of Aging on Proteins; R.W. Gracy. Engineering Dramatic Increases in the Stability of Subtilisin; P.N. Bryan. Increased Stability of Mutant Forms of Yeast Cytochrome c; D.R. Hickey, et al. Introduction to Formulation of Protein Pharmaceuticals; M.A. Hanson, S.K.E. Rouan. PEG Modified Proteins; G.E. Francis, et al. Stabilization of Protein Structure by Solvent Additives; S.N. Timasheff. Heat-Shock Proteins and their Potential Uses for Pharmaceutical Protein Production in Microorganisms; J.M. McCoy. Index.
Erscheint lt. Verlag | 30.11.1992 |
---|---|
Reihe/Serie | Pharmaceutical Biotechnology ; 3 |
Zusatzinfo | XXVI, 328 p. |
Verlagsort | New York |
Sprache | englisch |
Maße | 156 x 234 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
Medizin / Pharmazie ► Pharmazie ► PTA / PKA | |
Naturwissenschaften ► Biologie ► Biochemie | |
ISBN-10 | 0-306-44153-5 / 0306441535 |
ISBN-13 | 978-0-306-44153-0 / 9780306441530 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Arzneimittelverzeichnis für Deutschland (einschließlich …
Buch | Hardcover (2024)
Rote Liste Service GmbH (Verlag)
109,00 €